Information Journal Paper
APA:
Copy. (2020). Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. LANCET, 396(10249), 0-0. SID. https://sid.ir/paper/783668/en
Vancouver:
Copy. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. LANCET[Internet]. 2020;396(10249):0-0. Available from: https://sid.ir/paper/783668/en
IEEE:
Copy, “Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial,” LANCET, vol. 396, no. 10249, pp. 0–0, 2020, [Online]. Available: https://sid.ir/paper/783668/en